Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision
November 19, 2024 08:00 ET
|
IMPACT BIOMEDICAL INC
HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare...
Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease
October 15, 2024 06:00 ET
|
IMPACT BIOMEDICAL INC
HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in its innovative Linebacker™ technology platform. The Canadian...
Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth
September 23, 2024 08:00 ET
|
IMPACT BIOMEDICAL INC
NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting unique healthcare...